01
First sound of its kind
This groundbreaking immersive sound is engineered exclusively for mental-health clinicians and their patients undergoing psychedelic-assisted therapy (PAT) with Ketamine, Psilocybin, and MDMA treatments.
02
Clinician focused, patient informed
Our sound is a paradigm shift, providing clinicians with an effortless, uninterrupted immersive sound that transcends the limitations of conventional music and playlists. It brings science and technology together in one place so that clinicians, mental health institutions, and patients benefit from the latest innovations in immersive sound.
03
Our sound is different...for a reason
PsySonics' sound provides a sanctuary for patients, unearthing the profound significance of their therapeutic journey. Where the status quo playlists fall short, PsySonics ensures that the profound power of PAT is neither diluted nor compromised — because those needing healing deserve nothing less than extraordinary.

Story on MDMA
PsySonics' Founder and CEO, Rogers Masson, speaks about his journey on NPR with journalist, Will Stone.
Read the full article here.
Listen here...
What clinicians are saying...
Making a difference for patients...
Recommended by leaders in psychedelic-assisted therapy

The Pearl Psychedelic Institute,
the first US site to be authorized for MDMA-assisted therapy in PTSD

Our sound was used during the MAPS Expanded Access FDA program for investigational treatment of MDMA-assisted therapy for PTSD
A Better Way
PsySonics' Founder and CEO, Rogers Masson was a patient in the MAPS/FDA trials for MDMA. Inspired by his personal experience and insights in the trials, Rogers drew from his extensive expertise in sound engineering and immersive audio to create something truly innovative and new.
The result is PsySonics.

We'd love to hear from you
Contact us to learn more about PsySonics or talk with the team.
